The Latest Breaking News from Depression

There’s been a lot of hype around microdosing psychedelics as a potential treatment for depression, anxiety and PTSD — but what does the research actually say about it?

HC Wainwright initiated coverage on NRx Pharmaceuticals Inc (NASDAQ:NRXP) with a Buying rating and a price target of $2. Earlier today, the FDA declined to issue an Emergency Use Authorization for NRx's Zyesami for a subgroup of patients who also received Gilead Sciences Inc's (NASDAQ:GILD) remdesivir in addition to Zyesami. The analyst is bullish on: Significant potential for NRX-101 for…

In this edition of Inverse Daily, read about the gut-brain axis, organic eggs, alien atmospheres, and more.

ORLANDO, Fla. — The National Hurricane Center has issued a tropical storm warning for what it’s calling Potential Tropical Cyclone Two approaching the southern Windward Islands, one of three systems with a chance to form into the season’s next tropical depression or storm.

Roman Kemp has opened up about living with depression and why we need to be able to say the word suicide, as he continues his quest to break down the stigma around mental health

The Food and Drug Administration could be nearing a decision on Axsome Therapeutics' depression treatment, and AXSM stock rocketed Monday.

Axsome Therapeutics Inc (NASDAQ: AXSM) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment for MDD (depression).

COVID has left a lasting impact on education in a number of ways. Deficits in learning may never be fully redressed; backlogs, delays and more complexity in university admission will continue to be felt down the line; anxiety and depression are more prevalent.

FORT LAUDERDALE, Fla. — A tropical depression is likely to form this week from a tropical wave making its way across the Atlantic Ocean toward the southeastern Caribbean Sea, forecasters said Sunday.